For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Atomoxetine hydrochloride - Attention Deficit Hyperactivity Disorder (ADHD) - Children 6-17yrs
PAD Profile : Atomoxetine hydrochloride - Attention Deficit Hyperactivity Disorder (ADHD) - Children 6-17yrs
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
No indications returned.
Additional Documents
Committee Recommendations
Shared Care arrangements for children and adolescents with ADHD are in place with Surrey and Borders Partnership NHS Foundation Trust.
Guildford & Waverley, North West Surrey and Surrey Downs have agreed a Locally Commissioned Service (LCS) for practices entering into the shared care agreement with Surrey & Borders Partnership. The LCS supports the provision of an annual physical medication review by the GP (with an annual review by the specialist so that the patient continues to receive a 6-monthly review in accordance with the product license)
See below for a copy of the Shared care with LCS agreement
There is also a non-LCS shared care agreement that remains unchanged and is available for all non-LCS participating practices (see shared care agreement below)